ZNF503 and central nervous system cancer: To increase the reliability of the results, we validated the above findings in the CGGA325 and CGGA693 databases, which showed that ZNF503-AS2 may promote the activation of the oncogenic pathway, the stromal pathway, and the inflammatory response, which influences the biological behavior of glioma and contributes to the progression (S8 Fig).